Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer.
Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer. Breast Cancer Res. 2021 05 12; 23(1):54.
View in:
PubMed
subject areas
Animals
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Disease Models, Animal
Estrogen Receptor alpha
Female
Humans
MCF-7 Cells
Mice
Mutation
Neoplasm Metastasis
Piperazines
Protein Binding
Protein Conformation
Protein Kinase Inhibitors
Pyridines
Pyrrolidines
Receptors, Estrogen
Selective Estrogen Receptor Modulators
Tetrahydronaphthalenes
Treatment Outcome
authors with profiles
Geoffrey Greene